Definition of disease duration in ankylosing spondylitis

被引:44
作者
Feldtkeller, Ernst [1 ]
Erlendsson, Jon [2 ]
机构
[1] Ankylosing Spondylitis Int Federat, D-81671 Munich, Germany
[2] Ankylosing Spondylitis Int Federat, DK-8700 Horsens, Denmark
关键词
ankylosing spondylitis; disease duration; symptom onset; diagnosis delay;
D O I
10.1007/s00296-007-0499-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two definitions of the "disease duration" of ankylosing spondylitis (AS) have been used in the literature: (1) duration since first symptoms connected with AS and (2) duration since diagnosis of AS. To investigate how useful these definitions are for research, we reinvestigated the data of four surveys completed by patients with AS in the years since 1996. We found that the majority of the patients remembered the age at first symptoms with an accuracy of <= 1 year, and that the difference between both definitions (the delay in diagnosis) was between 9.8 and 10.4 years on average, with extreme values of more than 30 years being not very seldom. Because the error made using the duration since diagnosis as "disease duration" is much larger than the inaccuracy taken into account using the duration since first symptoms, only the duration since first symptoms connected with AS should be used as definition for the term "disease duration" of AS.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 14 条
[1]  
Brophy S, 2002, J RHEUMATOL, V29, P1236
[2]   Definition of disease duration in ankylosing spondylitis: reassessing the concept [J].
Davis, J. C. ;
Dougados, M. ;
Braun, J. ;
Sieper, J. ;
van der Heijde, D. ;
van der Linden, S. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) :1518-1520
[3]   Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis [J].
Feldtkeller, E ;
Vosse, D ;
Geusens, P ;
van der Linden, S .
RHEUMATOLOGY INTERNATIONAL, 2006, 26 (03) :234-239
[4]   Decrease its pain in prolonged spondyloarthritis favour male patients [J].
Feldtkeller, E .
AKTUELLE RHEUMATOLOGIE, 1998, 23 (06) :176-181
[5]   Distribution of disease activity and drug use in ankylosing spondylitis [J].
Feldtkeller, E ;
Hammel, L ;
Kellner, H .
AKTUELLE RHEUMATOLOGIE, 2005, 30 (04) :223-231
[6]   Scientific contributions of ankylosing spondylitis patient advocacy groups [J].
Feldtkeller, E ;
Bruckel, J ;
Khan, MA .
CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (04) :239-247
[7]  
Feldtkeller E, 1999, Z RHEUMATOL, V58, P21, DOI 10.1007/s003930050149
[8]   Disease outcome in male vs female sufferers from spondyloarthritis [J].
Feldtkeller, E .
AKTUELLE RHEUMATOLOGIE, 1998, 23 (05) :145-153
[9]   Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis [J].
Feldtkeller, E ;
Khan, MA ;
van der Heijde, D ;
van der Linden, S ;
Braun, J .
RHEUMATOLOGY INTERNATIONAL, 2003, 23 (02) :61-66
[10]  
FELDTKELLER E, 2007, UNPUB AKT RHEUMATOL